5 result(s) displayed (1 - 5 of 5):

Elan: Spin it and spin it fast (from Corporate Dealmaker)

Elan Corp. plc isn't wasting any time spinning off its drug delivery unit, Elan Drug Technologies. The company has already received first bids for the unit that it announced at the end of July it may spin off. Elan sunk, apparently, due to the unit's agreement with Biogen Idec Inc....

Posted on August 12, 2008 11:24 AM

Revlon's long-running makeover continues with Brazil sale (from Corporate Dealmaker)

Ron Perelman has employed six CEOs at Revlon Inc. since gaining control of the company in one of the signature hostile deals of the 1980s. Heavy debt and market missteps have smudged the venerable brand and its stock price too -- now about a dollar, compared with $54 10 years...

Posted on July 29, 2008 12:30 PM

Walgreen continues its specialty pharma push (from Corporate Dealmaker)

Seeking to further expand its home infusion pharmacy division, Walgreen Co. will acquire Express Scripts Inc.'s CuraScript Infusion Pharmacy Inc. for an undisclosed amount. CuraScript provides IV treatments for immune deficiency, chemotherapy and pain management. Express Scripts divested CuraScript because it was a noncore business. CuraScript will be integrated into...

Posted on June 10, 2008 1:43 PM

Preparing for a divestiture (from Corporate Dealmaker)

When it comes to selling a business, planning is everything. In the first of a two-part series, an experienced divestor explains.

Posted on March 12, 2008 2:10 PM

E&Y divestiture Webcast Thursday (from Corporate Dealmaker)

Ernst & Young is hosting a Webcast on Thursday at 12 p.m. on current trends in divesting business units and how carve-out financials can fuel valuation of divestitures. This second Webcast in E&Y's Divesting for Value series focuses on two essential elements: preparing robust audited and standalone financial statements, and...

Posted on February 13, 2008 5:01 PM